Familial cancer of unknown primary

被引:0
作者
Elie Rassy
Joseph Kattan
Nicholas Pavlidis
机构
[1] Gustave Roussy Institut,Department of Cancer Medicine
[2] Saint Joseph University,Department of Hematology
[3] University of Ioannina,Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine
来源
International Journal of Clinical Oncology | 2019年 / 24卷
关键词
Cancer of unknown primary; CUP; Familial; Genetics;
D O I
暂无
中图分类号
学科分类号
摘要
Cancer of unknown primary site (CUP) is a deadly disease diagnosed through metastases at various organs without primary tumor identification. Despite the major molecular and technological advances, the carcinogenesis of CUP remains enigmatic which hampers adequate study design of treatments leading to survival improvement. To date, the pathogenesis of CUP is still debatable with one hypothesis considering CUP simply a group of metastatic tumors with unidentified primaries and another considering it a distinct entity with specific genetic and phenotypic aberrations. Familial CUP seems to favor the first hypothesis due to common genetic predisposition factors between known primaries and CUP. Two clinical implications may be withdrawn from the pathogenesis of familial clustering of CUP. The detailed family history and environmental risk factors may orient towards the primary tumor identification. Smoking avoidance and adherence to general population guidelines for cancer screening would be strongly encouraged.
引用
收藏
页码:1328 / 1331
页数:3
相关论文
共 59 条
[1]  
Pavlidis N(2015)A mini review on cancer of unknown primary site: a clinical puzzle for the oncologists J Adv Res 6 375-382
[2]  
Khaled H(2012)Cancer of unknown primary site Lancet Lond Engl 379 1428-1435
[3]  
Gaafar R(2013)Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities Br J Cancer 109 1318-1324
[4]  
Pavlidis N(2015)Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol Off J Eur Soc Med Oncol 26 v133-v138
[5]  
Pentheroudakis G(2007)Cancer of unknown primary site: missing primary or missing biology? Oncologist 12 418-425
[6]  
Urban D(2018)Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary Eur J Cancer 105 28-32
[7]  
Rao A(2013)Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon Research Institute J Clin Oncol 31 217-223
[8]  
Bressel M(2016)Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis Lancet Oncol 17 1386-1395
[9]  
Fizazi K(2018)The current evidence for a biomarker-based approach in cancer of unknown primary Cancer Treat Rev 67 21-28
[10]  
Greco FA(2007)Forty years experience of treating cancer of unknown primary Acta Oncol 46 592-601